Alert: New Earnings Report (11/2/23)-Acadia Pharmaceuticals Inc (NASDAQ: ACAD).
For its third fiscal quarter (ending September 30), Acadia Pharmaceuticals Inc (NASDAQ: ACAD) has reported E.P.S. of $-0.40 compared to $-0.17 a year ago. This performance was $0.02 better than the consensus estimate of $-0.42. […]